Atossa Therapeutics (ATOS) Q2 2026 Earnings

8MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-1.11
-0.76
-0.4
-0.05

Details

Expected EPS
-0.99
Actual EPS
-1.11
Surprise EPS
-0.12
Surprise Percent
+12.12%

Description

Atossa Therapeutics (ATOS) has reported earnings of -1.11 per share for Q2 2026.

0 Comments

Share your thoughts